Genetic Disorders in Pathology
Learning Objectives
By the end of this page, you should be able to:
- Define a genetic disorder and distinguish chromosomal, single-gene, mitochondrial, and multifactorial causes.
- Recognize the inheritance pattern of a disease from a pedigree (autosomal dominant, autosomal recessive, X-linked recessive).
- Explain the mechanism and classic clinical picture of Down syndrome, cystic fibrosis, sickle cell disease, and Duchenne muscular dystrophy.
- Differentiate numerical chromosomal abnormalities (trisomy, monosomy) from structural ones (translocation, deletion, microdeletion).
- Choose the correct diagnostic test (karyotype, FISH, PCR) for a given clinical scenario.
- Avoid the most common exam traps around penetrance, carrier status, and recurrence risk.
Quick Answer
A genetic disorder is a disease caused by an abnormality in an individual's genome — this can be a whole extra chromosome (Down syndrome), a single mutated gene passed down in a family (cystic fibrosis, Duchenne muscular dystrophy), a mitochondrial DNA defect, or a mix of genetic and environmental factors (diabetes, hypertension). They matter because they explain why some diseases run in families, why some appear in one sex only, and why recurrence risk can be calculated for genetic counseling. Genetic disorders are grouped into four categories — chromosomal, single-gene (Mendelian), mitochondrial, and multifactorial — and each category has a distinct inheritance logic that determines who is at risk and how the disease is diagnosed.
Overview
Every genetic disorder ultimately comes down to one thing: information stored in DNA is wrong, missing, or present in the wrong dose. That "wrong information" can exist at three levels — an entire chromosome can be extra or missing (chromosomal disorder), a single gene's sequence can be altered (single-gene disorder), or the mitochondrial genome inherited only from the mother can be mutated (mitochondrial disorder). A fourth category, multifactorial disorders, results when genetic susceptibility combines with environmental triggers — most common adult diseases (type 2 diabetes, coronary artery disease, cleft lip) fall here.
Why does this classification matter for a clinician? Because the category tells you three practical things: how the disease is inherited (and therefore the recurrence risk for future children), how you diagnose it (karyotype vs. gene sequencing vs. clinical scoring), and whether relatives need to be screened. A pathologist reading a karyotype and a genetic counselor drawing a pedigree are really doing the same job — tracing how a single molecular error produces a predictable pattern of disease across a family.
Chromosomal Disorders
Chromosomal disorders involve a change in the number or structure of whole chromosomes — large enough to see under a microscope during karyotyping.
Numerical abnormalities (aneuploidy) — an incorrect chromosome number, usually from nondisjunction during meiosis (the chromosome pair fails to separate).
- Trisomy — three copies instead of two. Down syndrome (trisomy 21) is the classic example: an extra chromosome 21, occurring in about 1 in 700 live births, with risk rising sharply after maternal age 35 because older oocytes are more prone to nondisjunction.
- Monosomy — only one copy instead of two. Turner syndrome (45,X) is the only monosomy compatible with survival to birth; most monosomies are lethal in utero.
Structural abnormalities — the chromosome number is normal, but a piece has broken and rejoined incorrectly.
- Translocation — a segment of one chromosome attaches to another. A balanced translocation carrier is usually healthy but at high risk of producing unbalanced (and often nonviable or affected) gametes — this is why recurrent miscarriage prompts parental karyotyping.
- Deletion — a segment is lost. A microdeletion is too small to see on a standard karyotype and needs FISH; DiGeorge syndrome (22q11.2 deletion) is a classic microdeletion causing cardiac defects, hypocalcemia, and immunodeficiency.
- Mosaicism — an individual has two or more genetically distinct cell lines from a single zygote, because the nondisjunction error happened after fertilization. Mosaic Down syndrome can have a milder phenotype than full trisomy 21 because some cells are chromosomally normal.
Why it matters: chromosomal disorders are diagnosed by karyotype or FISH, not by looking for a single mutated gene — you're counting and mapping whole chromosomes, not reading a DNA sequence letter by letter.
Common misunderstanding: students often think "trisomy" only applies to chromosome 21. Trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) are equally testable, both far more severe than Down syndrome, and both usually fatal within the first year of life — a useful contrast for exam questions asking you to rank severity.
Single-Gene (Mendelian) Disorders
Single-gene disorders are caused by a mutation in one specific gene and follow classic Mendelian inheritance. Recognizing the pattern from a pedigree is one of the most heavily tested skills in pathology.
Autosomal Dominant
One copy of the mutant allele on a non-sex chromosome is enough to cause disease. Every affected person typically has an affected parent (unless it's a new mutation), the disease appears in every generation, and males and females are affected equally with roughly 50% of offspring of an affected parent inheriting the condition.
- Huntington's disease — a CAG trinucleotide repeat expansion in the HTT gene causes progressive neurodegeneration of the caudate nucleus and putamen, presenting with chorea, cognitive decline, and personality change, usually in mid-adulthood.
- Autosomal dominant conditions are often adult-onset (Huntington's, familial hypercholesterolemia) because severe disease that appears before reproductive age would be selected against.
Autosomal Recessive
Two copies of the mutant allele are needed. Affected individuals usually have unaffected, carrier parents; the disease can skip generations and clusters in siblings, not parent-to-child lines; consanguinity increases risk because relatives are more likely to share the same rare recessive allele.
- Cystic fibrosis — mutation in the CFTR chloride channel gene (most commonly ΔF508) causes thick, dehydrated mucus. This produces recurrent lung infections and bronchiectasis, pancreatic insufficiency with malabsorption, and abnormally salty sweat (the basis of the sweat chloride test). It is the most common lethal autosomal recessive disease in people of European ancestry.
- Sickle cell disease — a single point mutation in the beta-globin gene (glutamate → valine at position 6) produces HbS, which polymerizes under low oxygen and distorts red cells into a sickle shape. This causes vaso-occlusive painful crises, hemolytic anemia, and — because sickled cells clog the spleen — functional asplenia and increased risk of encapsulated organism infections. Carriers (sickle cell trait) are largely protected from severe malaria, which explains the allele's persistence in malaria-endemic regions.
X-Linked Recessive
The mutant gene sits on the X chromosome. Because males have only one X, a single mutant copy causes disease in males, while females need two copies (rare) or manifest mildly as carriers. There is no male-to-male transmission (fathers pass their Y, not X, to sons); an affected father's daughters are all obligate carriers; a carrier mother has a 50% chance of passing the mutation to each son (who will be affected) and each daughter (who will be a carrier).
- Duchenne muscular dystrophy (DMD) — mutation (usually a deletion) in the dystrophin gene, one of the largest genes in the genome, leads to absent dystrophin protein and progressive muscle fiber breakdown. Boys present around age 3–5 with proximal muscle weakness, a waddling gait, and the classic Gowers' sign (using hands to "walk up" the legs to stand). Pseudohypertrophy of the calves occurs because muscle is replaced by fat and fibrous tissue, not because muscle is genuinely bigger.
- Hemophilia A (factor VIII deficiency) follows the same X-linked recessive logic — think of Queen Victoria's pedigree as the textbook example of carrier transmission through royal families.
Why it matters clinically: the inheritance pattern predicts recurrence risk before a single test is run. A genetic counselor drawing a three-generation pedigree can often name the likely mode of inheritance just from the shape of the family tree.
Classification at a Glance
Diagnostic Tools
Matching the disorder to the right test is a frequent exam pattern:
- Karyotyping — spreads and stains all 46 chromosomes to detect numerical abnormalities (trisomy, monosomy) and large structural rearrangements (translocations). Cannot detect single-gene mutations or microdeletions.
- FISH (Fluorescence In Situ Hybridization) — uses a fluorescent DNA probe to detect a specific sequence on a chromosome. Ideal for microdeletions too small for a standard karyotype (e.g., 22q11.2 deletion in DiGeorge syndrome) and for confirming specific translocations (e.g., BCR-ABL in CML).
- PCR and gene sequencing — amplifies and reads specific DNA segments, the method of choice for single-gene disorders where you need to find a point mutation, small deletion, or repeat expansion (e.g., CFTR mutation testing, HTT CAG repeat count).
Key Terms
| Term | Definition |
|---|---|
| Genotype | The actual genetic makeup of an individual at a locus (e.g., heterozygous carrier). |
| Phenotype | The observable physical or clinical expression of the genotype. |
| Penetrance | The proportion of people with a disease-causing genotype who actually show the phenotype; incomplete penetrance means some mutation carriers stay asymptomatic. |
| Expressivity | The degree to which a phenotype is expressed among those who do show it; variable expressivity explains why siblings with the same mutation can have different severity. |
| Carrier | A person with one copy of a recessive disease allele who is typically unaffected but can pass it to offspring. |
| Aneuploidy | An abnormal chromosome number that is not an exact multiple of the haploid set (e.g., trisomy, monosomy). |
| Nondisjunction | Failure of chromosome pairs (or sister chromatids) to separate properly during meiosis, the main cause of aneuploidy. |
| Mosaicism | Presence of two or more genetically distinct cell lines in one individual arising from a single fertilized egg. |
| Microdeletion | A chromosomal deletion too small to detect by standard karyotype, requiring FISH or molecular testing. |
| Trinucleotide repeat expansion | An abnormal increase in the number of a repeated three-base DNA sequence, the mechanism behind Huntington's disease and fragile X syndrome. |
| Consanguinity | Reproduction between closely related individuals, which raises the risk of autosomal recessive disorders by increasing the chance both parents carry the same rare allele. |
Common Mistakes
Misconception 1: "A carrier of a recessive disease will show mild symptoms." Why it's wrong: Carriers (heterozygotes) have one normal and one mutant allele; the normal allele's protein product is usually sufficient for normal function, so carriers are typically asymptomatic — not "mildly affected." Correct explanation: Sickle cell trait carriers, for example, are generally healthy and only show symptoms under extreme hypoxic stress (high altitude, severe dehydration). Disease requires two mutant alleles (homozygous or compound heterozygous).
Misconception 2: "If a disease is autosomal dominant, every child of an affected parent will get it." Why it's wrong: This confuses dominant inheritance (only one mutant copy needed to cause disease if inherited) with certainty of transmission. Correct explanation: Each child of an affected heterozygous parent has a 50% chance of inheriting the mutant allele, not 100%. Whether that child then shows disease also depends on penetrance, which for some autosomal dominant conditions is incomplete.
Misconception 3: "All chromosomal abnormalities are inherited from a parent." Why it's wrong: Most trisomies (like Down syndrome) arise from a de novo nondisjunction event during gamete formation, not from a parent who is also affected. Correct explanation: Parents of a child with trisomy 21 usually have completely normal karyotypes; the extra chromosome came from an error in that particular egg or sperm. The exception is when Down syndrome results from a parental balanced translocation, which is why karyotyping the affected child (not just assuming standard trisomy) matters for accurate recurrence-risk counseling.
Comparison and Connections
| Feature | Autosomal Dominant | Autosomal Recessive | X-linked Recessive | Chromosomal (e.g., Down syndrome) |
|---|---|---|---|---|
| Copies of mutant allele needed | One | Two | One (males), two (females, rare) | Not applicable — whole chromosome affected |
| Typical parents of affected child | One parent affected | Both parents unaffected carriers | Mother is usually a carrier | Usually both parents have normal karyotypes |
| Generational pattern | Every generation | Can skip generations | Skips generations, clusters in maternal male relatives | Usually sporadic, risk rises with maternal age |
| Classic example | Huntington's disease | Cystic fibrosis, sickle cell disease | Duchenne muscular dystrophy, hemophilia A | Trisomy 21 (Down syndrome) |
| Primary diagnostic test | Gene sequencing (e.g., CAG repeat count) | Gene sequencing / sweat chloride / hemoglobin electrophoresis | Gene sequencing / creatine kinase + dystrophin studies | Karyotype ± FISH |
Practice Questions
Recall 1. What is the underlying chromosomal abnormality in Down syndrome, and what test confirms it? Answer guidance: Trisomy 21 — an extra copy of chromosome 21, most often from meiotic nondisjunction. Confirmed by karyotype analysis.
Recall 2. Name the gene and typical mutation responsible for cystic fibrosis. Answer guidance: The CFTR gene, most commonly the ΔF508 deletion, which impairs the chloride channel and leads to thick mucus secretions.
Understanding 1. Explain why sickle cell trait persists at high frequency in populations from malaria-endemic regions despite being a disease-causing allele. Answer guidance: Heterozygous carriers (trait) are largely healthy but their red cells are less hospitable to the malaria parasite, giving a survival advantage in endemic areas — a classic example of heterozygote advantage/balanced polymorphism, explaining why the recessive allele hasn't been eliminated by selection.
Understanding 2. Why can two unaffected parents have a child with an autosomal recessive disorder, but two unaffected parents cannot (typically) have a child with an autosomal dominant disorder? Answer guidance: In recessive disease, unaffected parents can each be silent heterozygous carriers; if both pass their mutant allele, the child becomes homozygous and affected. In dominant disease, one copy of the mutant allele is enough to cause disease, so an unaffected parent (by definition) does not carry it — an affected child would imply a new (de novo) mutation rather than inheritance from an unaffected parent.
Application 1. A 3-year-old boy presents with proximal muscle weakness, a waddling gait, and uses his hands to push up off his thighs to stand from a sitting position. His maternal uncle had a similar history and died young. What is the diagnosis and inheritance pattern? Answer guidance: Duchenne muscular dystrophy — X-linked recessive. The Gowers' sign (using hands to walk up the legs) is classic, and the affected maternal uncle fits the X-linked pattern of male relatives on the mother's side being affected.
Application 2. A couple who are first cousins have a child with cystic fibrosis. Their next pregnancy — what is the recurrence risk, and why does consanguinity raise the family's risk in the first place? Answer guidance: 25% recurrence risk, because both parents are obligate carriers (Aa × Aa cross gives 1/4 aa). Consanguinity raises the risk of recessive disease because related individuals are more likely to both carry the same rare allele inherited from a shared ancestor.
Analysis 1. A karyotype from a couple with recurrent miscarriages shows one partner has a balanced chromosomal translocation. Explain how a "balanced" abnormality in a phenotypically normal parent can cause pregnancy loss. Answer guidance: A balanced translocation carrier has the normal total amount of genetic material, just rearranged, so they are phenotypically unaffected. During meiosis, however, the rearranged chromosomes can segregate unevenly into gametes, producing embryos with unbalanced genetic material (extra or missing segments) — which is often incompatible with viable development, causing miscarriage.
Analysis 2. Compare Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) in terms of severity and survival, and explain why the difference exists despite all three being trisomies. Answer guidance: Down syndrome is the mildest and most compatible with long-term survival; Edwards and Patau syndromes cause severe multi-organ malformations and most affected infants die within the first year. The difference reflects how much coding DNA and how many critical developmental genes are on the extra chromosome — chromosome 21 is the smallest human autosome with relatively few genes, so having an extra copy is comparatively better tolerated than an extra (larger, more gene-dense) chromosome 18 or 13.
FAQ
1. What's the difference between a chromosomal disorder and a single-gene disorder? A chromosomal disorder involves an entire extra, missing, or rearranged chromosome, visible on a karyotype. A single-gene disorder is a mutation within one specific gene, which requires molecular testing (PCR, sequencing) to detect — the chromosome count itself looks completely normal.
2. Why does maternal age increase the risk of Down syndrome but not most single-gene disorders? Oocytes are arrested in meiosis from before birth until ovulation, sometimes for decades, and this prolonged arrest makes the chromosome-separating machinery more error-prone with age, increasing nondisjunction risk. Single-gene mutations, in contrast, are usually inherited from existing parental DNA sequence and aren't strongly tied to the age-related meiotic errors that cause aneuploidy (though paternal age does raise the risk of certain new dominant mutations).
3. Can a person be a carrier of an X-linked disease and still show symptoms? Yes, though usually mild. Female carriers have one normal and one mutant X allele, but X-inactivation (lyonization) is random — if by chance more of the normal X copies get inactivated in a particular tissue, that carrier can show some symptoms (a "manifesting carrier"), for example mild muscle weakness in a Duchenne muscular dystrophy carrier.
4. Is genetic testing during pregnancy the same as a karyotype done after birth? The technique can be the same (analyzing chromosomes from fetal cells obtained via amniocentesis or chorionic villus sampling), but prenatal screening often starts with non-invasive tests (like cell-free fetal DNA screening) that estimate risk, with karyotype or FISH used to confirm a suspected chromosomal abnormality.
5. Why do some genetic disorders appear in every generation while others skip generations? This comes down to dominant versus recessive inheritance. Dominant conditions need only one mutant copy, so an affected parent has a good chance of having an affected child every generation. Recessive conditions require two copies, so the disease can hide in unaffected carrier parents for one or more generations before two carriers happen to have children together.
Quick Revision
- Genetic disorders fall into four categories: chromosomal, single-gene (Mendelian), mitochondrial, and multifactorial.
- Down syndrome = trisomy 21, usually from meiotic nondisjunction, risk rises with maternal age; karyotype confirms diagnosis.
- Trisomy 18 (Edwards) and trisomy 13 (Patau) are more severe than Down syndrome and usually fatal in infancy.
- Autosomal dominant: one mutant allele causes disease, affects every generation, 50% transmission risk (e.g., Huntington's disease).
- Autosomal recessive: two mutant alleles needed, unaffected carrier parents, 25% recurrence risk, raised by consanguinity (e.g., cystic fibrosis, sickle cell disease).
- Cystic fibrosis: CFTR gene mutation (ΔF508), thick mucus, recurrent lung infections, pancreatic insufficiency, positive sweat chloride test.
- Sickle cell disease: beta-globin point mutation, vaso-occlusive crises, hemolytic anemia; carriers (trait) get malaria protection.
- X-linked recessive: no male-to-male transmission, carrier mothers pass to 50% of sons (affected) and 50% of daughters (carriers) — e.g., Duchenne muscular dystrophy, hemophilia A.
- Duchenne MD: dystrophin gene mutation, proximal weakness, Gowers' sign, calf pseudohypertrophy, onset around age 3–5.
- Karyotype detects numerical/large structural abnormalities; FISH detects microdeletions/specific sequences; PCR/sequencing detects point mutations.
- Balanced translocation carriers are phenotypically normal but at risk of producing unbalanced, often nonviable gametes.
- Penetrance = probability the genotype causes visible disease; expressivity = how severe the disease is once it appears — these two explain "same mutation, different outcome" scenarios.
Related Topics
Prerequisites
- Basic cell biology: mitosis vs. meiosis, chromosome structure
- Mendelian genetics: dominant/recessive alleles, Punnett squares
Related Topics
- Molecular diagnostic techniques (PCR, FISH, next-generation sequencing)
- Prenatal screening and diagnosis (amniocentesis, chorionic villus sampling, cell-free fetal DNA)
- Cancer genetics and oncogenes (somatic vs. germline mutations)
Next Topics
- Pediatric genetic syndromes and dysmorphology
- Gene therapy and CRISPR-based treatment approaches
- Genetic counseling and recurrence-risk calculation